Michael Schaeffer
Director/Board Member en VIVORYON THERAPEUTICS N.V. .
Fortuna: - $ al 31/03/2024
Perfil
Dr. Michael Schaeffer is an Executive Director & Chief Business Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Schaeffer was previously employed as a Chief Executive Officer & Managing Director by Crelux GmbH and a Chief Executive Officer & Managing Director by SiREEN AG.
He received his doctorate degree from Ludwig-Maximilians-Universität München.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
04/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Michael Schaeffer
Empresas | Cargo | Inicio |
---|---|---|
VIVORYON THERAPEUTICS N.V. | Director/Board Member | - |
Antiguos cargos conocidos de Michael Schaeffer.
Empresas | Cargo | Fin |
---|---|---|
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Chief Executive Officer | 01/03/2016 |
SiREEN AG | Chief Executive Officer | 01/01/2004 |
Formación de Michael Schaeffer.
Ludwig-Maximilians-Universität München | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
VIVORYON THERAPEUTICS N.V. | Health Technology |
Empresas privadas | 2 |
---|---|
SiREEN AG | Commercial Services |
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Schaeffer